Boston Scientific reports cyberattack that disrupts operations and order processing
Boston Scientific disclosed in an SEC filing on Aug. 26 that it detected a cybersecurity incident the previous day, marking the latest medtech cyberattack of the year.
The breach impacted several of the company’s information technology systems and business applications, causing a global disruption to operations, including the ability to process and ship customer orders.
The company is actively working to restore the affected systems, but it has not provided a timeline for full recovery and has not yet determined whether the incident will have a material impact on its business.
Boston Scientific’s shares fell about 3.5% in pre‑market trading following the announcement, adding pressure as the firm continues a multi‑year restructuring program slated for completion by 2029.
This writeup was produced by pharmadog from original reporting by Fierce Biotech.
Original headline: “Boston Scientific hit by cyberattack causing ‘disruptions’ to parts of its business”
read at Fierce Biotech ↗
comments(0)
5-min edit window · permanent after that